Medical conditions
Disease & indication intelligence
Browse pharmaceutical intelligence by disease and indication — associated drugs, pipeline programs, and latest news for oncology, metabolic, neurology, and immunology conditions.
Quick answer
Disease hubs connect indications to indexed drugs, clinical pipeline programs, and regional news coverage. Each hub is built from live entity and editorial data — only conditions with associated therapies or news are listed.
Browse by condition
-
Non-Small Cell Lung Cancer
NSCLC therapies, PD-1/L1 inhibitors, and pipeline readouts.
View hub → -
Breast Cancer
HER2, HR+, and triple-negative breast cancer drug landscape.
View hub → -
Obesity
GLP-1 and incretin therapies reshaping metabolic disease.
View hub → -
Diabetes
Type 2 diabetes and cardiometabolic drug development.
View hub → -
Alzheimer's Disease
Amyloid, tau, and emerging neurology pipeline.
View hub → -
Multiple Sclerosis
CNS immunology and MS disease-modifying therapies.
View hub → -
Rheumatoid Arthritis
Autoimmune biologics and JAK inhibitors.
View hub → -
Psoriasis
IL-17, IL-23, and dermatology biologics.
View hub → -
Atopic Dermatitis
JAK and biologic options in inflammatory skin disease.
View hub → -
Heart Failure
Cardiometabolic and cardiovascular pipeline.
View hub → -
COVID-19
Antivirals, vaccines, and pandemic preparedness assets.
View hub → -
HIV
Antiretroviral therapies and long-acting formulations.
View hub →